Philip Philip, MD of Karmanos Cancer Institute discusses the impact of PEGPH20 on care of patients with metastatic pancreatic cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Impact of PEGPH20 in metastatic pancreatic cancer
Philip Philip, MD of Karmanos Cancer Institute discusses the impact of PEGPH20 on care of patients with metastatic pancreatic cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.